Australia Court Issues Temporary Injunction Prohibiting Smith & Nephew from Selling Negative Pressure Wound Therapy Foam Dressing Kit.SAN ANTONIO -- Kinetic Concepts, Inc. (NYSE NYSE See: New York Stock Exchange : KCI KCI Kansas City International (airport) KCI Kennel Club of India KCI Key Club International KCI Korea Concrete Institute KCI Kitchener Collegiate Institute KCI Kids Central, Inc. KCI The Kitchen Collection, Inc. KCI Kodak Canada Inc. ) announced today that The Federal Court of Australia The Federal Court of Australia is the Australian court in which most civil disputes, and some summary criminal matters, governed by federal law are decided. Cases are heard at first instance by single Judges. , Victoria District Registry, issued a temporary injunction temporary injunction n. a court order prohibiting an action by a party to a lawsuit until there has been a trial or other court action. A temporary injunction differs from a "temporary restraining order" which is a short-term, stop-gap injunction issued pending a prohibiting Smith & Nephew (LSE LSE - Language Sensitive Editor : SN; NYSE: SNN SNN Samenwerkingsverband Noord-Nederland SNN Sanane Inc. SNN Schoolnet News Network (Canada) SNN Shannon, Ireland - Shannon (Airport Code) SNN Special Needs Network SNN Sarimanok News Network ) from selling foam dressing kits for negative pressure wound therapy Negative Pressure Wound Therapy (NPWT) is the use of sub-atmospheric pressure to promote or assist wound healing, or to remove fluids from a wound site. History Negative Pressure Wound Therapy in its present form was developed by Dr. Louis Argenta and Dr. in Australia until the court can rule on the patent infringement action brought against Smith & Nephew by KCI. Smith & Nephew is allowed to provide trial samples in limited circumstances during the interim. A UK court already has issued an injunction against Smith & Nephew, and courts in the U.S. and Germany plan to consider the grant of an injunction. A trial date on the infringement and validity of the patent is expected to be set in the Australian courts for 2010. "We are pleased the Australian Court has granted this important injunction," said Stephen Seidel sei·del n. A beer mug. [German, from Middle High German s  del, from Latin situla, bucket.]Noun 1. , KCI Executive Vice President, Chief Administrative Officer A chief administrative officer (CAO) is responsible for administrative management of private, public or governmental corporations. The CAO is one of the highest ranking members of an organization, managing daily operations and usually reporting directly to the chief executive and General Counsel. "This ruling helps confirm the importance of patents in a competitive and innovative environment. Protecting patents represents a fundamental step due any innovative company, and it encourages new and more effective alternatives for patients. Those in need of medical care deserve the best our industry has to offer - unique, innovative ideas that provide proven therapies for those administering and receiving care. Providing those ideas and therapies remains KCI's top priority." About KCI Kinetic Concepts, Inc. (NYSE: KCI), is a leading global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets. Headquartered in San Antonio, Texas “San Antonio” redirects here. For other uses, see San Antonio (disambiguation). San Antonio is the second most populous city in Texas, the third most populous metropolitan area in Texas, and is the seventh most populous city in the United States. As of the 2006 U.S. , KCI's success spans more than three decades and can be traced to a history deeply rooted in innovation and a passion for significantly improving the healing -- and the lives -- of patients around the world. KCI's three primary businesses include: Advanced Wound Care--Includes KCI's proprietary Vacuum Assisted Closure([R]), or V.A.C.([R]) Therapy System, which has been clinically demonstrated to promote wound healing through unique mechanisms of action while reducing the overall cost of treating patients with complex wounds. Regenerative Medicine--Represented by KCI's LifeCell business and includes tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects. Therapeutic Support Systems--Includes specialty hospital beds, mattress replacement systems and overlays designed to address pulmonary complications associated with immobility, reduce skin breakdown and assist caregivers in the safe and dignified handling of patients of size. The company employs 6,700 people and markets its products in more than 20 countries. For more information about KCI, and how its products are changing the practice of medicine, visit www.KCI1.com. Forward-Looking Statements This press release contains forward-looking statements regarding management's expectations for the outcome of litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. and the company's future plans for the commercialization of new products. Forward-looking statements may contain words such as believes, expects, anticipates, estimates, projects, intends, should, seeks, future, continue, or the negative of such terms, or other comparable terminology. Forward-looking statements are subject to risks, uncertainties, assumptions and other factors that are difficult to predict and that could cause actual results to vary materially from those expressed in or indicated by them. Additional risks and factors are identified in KCI's filings with the U.S. Securities Exchange Commission (the SEC), including its Annual Report on Form 10-K for the fiscal year ending December 31, 2008, and Quarterly Report on Form 10-Q for the quarter ended March 31, 2009, which are available on the SEC's Web site at http://www.sec.gov. KCI undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion